Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant radiotherapy and chemotherapy in FIGO Ib2, IIa > 4 cm or IIb cervical cancer.
Study documentation
Trial StatusClosed for recruitment
DatesDate of activation: 19-Mar-02
Closed on : 01-Jul-14
Data management at EORTCFull
Randomized trialYes
Targeted Sample sizeEORTC Groups: 625 - All Groups: 625
Number of steps1
Study StaffStefano Greggi (Study Coordinator) - Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli
Gemma Kenter (Study Coordinator) - Academisch Medisch Centrum - Universiteit van Amsterdam, Amsterdam
Fabio Landoni (Study Coordinator) - Istituto Europeo di Oncologia, Milano
Corneel Coens (Statistician) - EORTC Headquarters, Brussels
Maarten De Rouck (Data Manager) - EORTC Headquarters, Brussels
Ellen Peeters (Project Manager) - EORTC Headquarters, Brussels, ellen.peeters( at )eortc.be, +32 27741082
Type of cancerCervical
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT numberNCT00039338